Loading clinical trials...
Loading clinical trials...
The Effects of Intranasal Oxytocin on Approach Bias and Craving in Moderate to Heavy Alcohol Drinkers
Conditions
Interventions
Oxytocin
Placebo
Locations
1
United States
University of California, San Francisco
Berkeley, California, United States
Start Date
November 1, 2023
Primary Completion Date
April 20, 2024
Completion Date
April 20, 2024
Last Updated
June 6, 2022
NCT05855668
NCT07071779
NCT07413458
NCT06939088
NCT06793488
NCT06648642
Lead Sponsor
Jennifer Mitchell
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions